A detailed history of Cheviot Value Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cheviot Value Management, LLC holds 30,094 shares of ABBV stock, worth $4.97 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
30,094
Previous 31,267 3.75%
Holding current value
$4.97 Million
Previous $5.36 Million 10.82%
% of portfolio
1.21%
Previous 1.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $192,184 - $233,814
-1,173 Reduced 3.75%
30,094 $5.94 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $93,957 - $109,721
-607 Reduced 1.9%
31,267 $5.36 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $80,389 - $91,596
-503 Reduced 1.55%
31,874 $5.8 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $279,465 - $314,744
-2,031 Reduced 5.9%
32,377 $5.02 Million
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $32,729 - $37,889
-245 Reduced 0.71%
34,408 $5.13 Million
Q2 2023

Nov 07, 2023

BUY
$132.51 - $164.9 $100,972 - $125,653
762 Added 2.25%
34,653 $4.67 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $56,108 - $64,617
-388 Reduced 1.13%
33,891 $5.4 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $2,627 - $3,151
-19 Reduced 0.06%
34,279 $5.54 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $49,255 - $56,492
-367 Reduced 1.06%
34,298 $4.6 Million
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $18,578 - $23,619
-135 Reduced 0.39%
34,665 $5.31 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $277,026 - $343,711
2,099 Added 6.42%
34,800 $5.64 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $19,552 - $24,739
-182 Reduced 0.55%
32,701 $4.43 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $2,872 - $3,261
-27 Reduced 0.08%
32,883 $3.55 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $32,404 - $36,100
-308 Reduced 0.93%
32,910 $3.71 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $226,799 - $249,678
2,217 Added 7.15%
33,218 $3.6 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $78,155 - $105,518
971 Added 3.23%
31,001 $3.32 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $7,731 - $9,074
-90 Reduced 0.3%
30,030 $2.63 Million
Q2 2020

Aug 17, 2020

SELL
$73.37 - $98.18 $63,465 - $84,925
-865 Reduced 2.79%
30,120 $2.96 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $2.05 Million - $3.11 Million
-31,763 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $51,068 - $63,897
-708 Reduced 2.18%
31,763 $2.81 Million
Q3 2019

Nov 15, 2019

SELL
$62.98 - $75.72 $11,651 - $14,008
-185 Reduced 0.57%
32,471 $2.46 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $6,767 - $8,649
-103 Reduced 0.31%
32,656 $2.38 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $55,232 - $65,005
-716 Reduced 2.14%
32,759 $2.64 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $783,949 - $966,820
-10,070 Reduced 23.13%
33,475 $3.09 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $151,058 - $167,929
-1,699 Reduced 3.76%
43,545 $4.12 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $152,266 - $180,166
-1,696 Reduced 3.61%
45,244 $4.19 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $816,864 - $1.09 Million
-8,878 Reduced 15.91%
46,940 $4.44 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $452,636 - $496,353
-5,054 Reduced 8.3%
55,818 $5.4 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $76,485 - $97,695
-1,095 Reduced 1.77%
60,872 $5.41 Million
Q2 2017

Aug 11, 2017

BUY
N/A
61,967
61,967 $4.49 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cheviot Value Management, LLC Portfolio

Follow Cheviot Value Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.